Table 1. Baseline characteristics all patients.
| PATIENT CHARACTERISTICS | Culture negative (213) | Culture positive (169) |
| No of males/No of females | 136/77 | 111/58 |
| Age (yrs) | 18 (2–64) | 17 (2.75–50) |
| Number Aged <14 years (%) | 79(37.1) | 60 (35.5) |
| Weight (Kg) | 44 (10–80) | 46 (10–73) |
| Duration of fever before treatment (days) | 5 (0–21) | 5 (2–23) |
| Median oral temperature at presentation(95% CI, range) (in degrees C) | 38.7 (38.6–39; 36.5–40.7) | 39(38.8–39.2; 36.8–41) |
| Headache, Number with (%) (median duration [days]) | 204 (95.7) (4) | 164 (97.0) (5.) |
| Anorexia, Number with (%) (median duration [days]) | 160 (75.1) [4] | 129 (76.3) [4] |
| Abdominal Pain, Number with (%) (median duration [days]) | 88 (41.3) [4] | 80 (47.3) [4] |
| Cough, Number with (%) (median duration [days]) | 83 (39.0) [3] | 59 (34.9) [3] |
| Diarrhoea, Number with (%) (median duration [days]) | 45 (21.1) [3] | 41 (24.3) [3] |
| Vomiting, Number with (%) (median duration [days]) | 30 (14.1)[1] | 27 (16.0) [2] |
| Abdominal tenderness ( n [%]) ) | 32 [15.1] | 23 [13.6] |
| Splenomegaly ( n [%]) | 18 [8.5] | 18 [10.6] |
| Hepatomegaly ( n [%]) | 12 [5.76] | 9[5.3] |
| Hematocrit (in%) | 40 (27–53) | 40 (29–50) |
| White Cell Count (in ×1000 per microlitre) | 7.2 (2.3–24.2) | 6.7 (3.0–20.0) |
| Platelet Count (in ×1000 per microlitre) | 192 (66–546) | 180 (65–380) |
| * ALT ( in U/L ) | 30(11–240) | 37 (12–200) |
| **AST ( in U/L ) | 43 (20–354) | 52 (21–169) |
| Total Bilirubin ( in mg/dL ) | 0.8 (0.17–3.6) | 0.89 (0.18–3.2) |
Baseline epidemiological, clinical and laboratory features at presentation of all intention to treat patients showing a comparison between culture positive and culture negative groups.
*
ALT (serum alanine aminotransferase) normal range 5–34 U/L
**
AST (serum aspartate aminotransferase) normal range 5–34 U/L
All data presented as median (range) unless specified.